ABBV AbbVie Inc. Common Stock
$264,49
Prix · Aoû 19, 2026
Données fondamentales au Aoû 3, 2026
Fourchette 52 semaines
$191–$267
96% of range
Note des analystes
BUY
38 analysts
Objectif de cours
$276
+5% upside
P/E (TTM)
96.8
ROE
15367.3%
Marge nette
6.9%
À propos de AbbVie Inc. Common Stock Présentation de l'entreprise depuis Wikipedia
AbbVie est une entreprise de biotechnologie américaine dont le siège est situé à North Chicago dans l’Illinois. Elle est classée cinquième plus grande société mondiale de biotechnologie en termes de capitalisation boursière. En 2023 elle était au 74e rang du Forbes Global 2000.
Lire la suite
AbbVie est une entreprise de biotechnologie américaine dont le siège est situé à North Chicago dans l’Illinois. Elle est classée cinquième plus grande société mondiale de biotechnologie en termes de capitalisation boursière. En 2023 elle était au 74e rang du Forbes Global 2000.
Histoire
Le 19 octobre 2011 Abbott Laboratories a annoncé son intention de se scinder en deux sociétés cotées en bourse, séparant ainsi sa division de fabrication de produits pharmaceutiques basée sur la recherche. Cette nouvelle société nommée AbbVie a été créée le 10 avril 2012. La séparation est entrée en vigueur le 1er janvier 2013 et AbbVie a été officiellement introduite à la Bourse de New York le 2 janvier 2013.
Le nom « AbbVie » est dérivé d’une combinaison de « Abbott », le nom de son ancienne société mère, avec le suffixe « vie ».
En 2014, AbbVie souhaite acquérir Shire, après plusieurs refus de ce dernier, celui-ci accepte l'acquisition pour un montant de 32 milliards de livres soit environ 54,7 milliards de dollars. La nouvelle compagnie aura son siège à Jersey. En octobre 2014, AbbVie annule la transaction après une modification des règles fiscales américaines, qui rend moins attractifs, les inversions. AbbVie paye à Shire 1,64 milliard de dédommagements pour l'annulation de la transaction.
En mars 2015, AbbVie acquiert pour 21 milliards de dollars Pharmacyclics, une entreprise californienne spécialisée dans le traitement de la leucémie ayant 600 employés pour 730 millions de chiffres d'affaires.
En avril 2016, AbbVie annonce l'acquisition de Stemcentrx pour 5,8 milliards de dollars.
La même année, elle entre en conflit avec le laboratoire Amgen pour la propriété intellectuelle du médicament Humira, nom commercial de la molécule Adalimumab, une de ses principales sources de revenus. Ce conflit est par la suite résolu.
En juin 2019, AbbVie rachète Allergan, entreprise américaine à l'origine de la création du Botox, pour 63 milliards de dollars. Il s'agit de la plus grosse acquisition du groupe depuis sa création.
Le 7 décembre 2023 AbbVie annonce la signature d'un accord en vertu duquel il fera l'acquisition de Cerevel Therapeutics pour 8,7 milliards de dollars. Cerevel dispose d'un portefeuille composé de plusieurs traitements au stade clinique et préclinique ayant un potentiel pour plusieurs maladies notamment la schizophrénie, la maladie de Parkinson et les troubles de l'humeur.
En février 2024 l'entreprise finalise l'achat d'ImmunoGen pour 10,1 milliards de dollars. Avec cet achat AbbVie renforce son portefeuille en oncologie et notamment dans le traitement contre le cancer de l'ovaire.
Le 25 mars 2024 AbbVie annonce acquérir pour 137 millions de dollars Landos Biopharma, une société biopharmaceutique axée sur le développement de produits thérapeutiques oraux pour les patients atteints de maladies auto-immunes.
Le 27 juin 2024, AbbVie annonce l'acquisition pour 250 millions de dollars de Celsius Therapeutics, une société de biotechnologie exerçant dans la mise au point de thérapies pour les patients atteints de maladies inflammatoires.
Le 29 octobre 2024, AbbVie conclu un accord définitif pour acquérir Aliada Therapeutics dans le cadre d’une transaction de 1,4 milliard de dollars.
En juin 2026, AbbVue annonce l'acquisition de Apogee, spécialisée dans les maladies inflammatoires, pour 10,9 milliards de dollars.
Actionnaires
Principaux actionnaires au 19 août 2024:
== Références ==
Source : Wikipedia, CC BY-SA 4.0 · Voir sur Wikipedia ↗
ABBV Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$264.49
Capitalisation Boursière
—
P/E (TTM)
96.8
BPA (TTM)
$2.36
Revenus (TTM)
$61.16B
Rendement div.
—
ROE
15367.3%
Dette/Capitaux propres
-0.8
Fourchette 52 semaines
$191 – $267
ABBV Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$61.16B
2016-12-31
→
2025-12-31
BPA
$2.36
2016-12-31
→
2025-12-31
Flux de trésorerie libre
$17.82B
2016-12-31
→
2025-12-31
Marges
6.9%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
ABBV
Médiane des pairs
P/E (TTM)
96.8
24.7
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
ABBV
Médiane des pairs
Operating Margin (Marge d'exploitation)
24.6%
—
Net Profit Margin (Marge nette)
6.9%
17.4%
ROA
3.1%
6.7%
ROE
15367.3%
18.8%
ROIC
-1254.6%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
ABBV
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
-0.8
—
Current Ratio (Ratio de liquidité)
0.7
3.1
Quick Ratio (Ratio de liquidité réduite)
0.4
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
ABBV
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
8.6%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
1.8%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
5.9%
—
EPS YoY (BPA Année/Année)
-1.3%
—
Net Income YoY (Bénéfice net YoY)
-1.2%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
ABBV
Médiane des pairs
Payout Ratio (Ratio de distribution)
275.8%
—
Dividendes Rendement, ratio de distribution, historique des dividendes, CAGR à 5 ans
Rendement du Dividende
—
Ratio de distribution
275.8%
CAGR des dividendes sur 5 ans
—
| Date ex-dividende | Montant |
|---|---|
| 15 juillet 2026 | $1,7300 |
| 15 avril 2026 | $1,7300 |
| 16 janvier 2026 | $1,7300 |
| 15 octobre 2025 | $1,6400 |
| 15 juillet 2025 | $1,6400 |
| 15 avril 2025 | $1,6400 |
| 15 janvier 2025 | $1,6400 |
| 15 octobre 2024 | $1,5500 |
| 15 juillet 2024 | $1,5500 |
| 12 avril 2024 | $1,5500 |
| 12 janvier 2024 | $1,5500 |
| 12 octobre 2023 | $1,4800 |
| 13 juillet 2023 | $1,4800 |
| 13 avril 2023 | $1,4800 |
| 12 janvier 2023 | $1,4800 |
| 13 octobre 2022 | $1,4100 |
| 14 juillet 2022 | $1,4100 |
| 13 avril 2022 | $1,4100 |
| 13 janvier 2022 | $1,4100 |
| 14 octobre 2021 | $1,3000 |
ABBV Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
38 analystes
- Achat fort 9 23,7%
- Achat 22 57,9%
- Conserver 7 18,4%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
29 analystes · 2026-08-18
Médiane
$280.00
Maintenant
$264.49
Bas
$200.00
Haut
$328.00
Objectif médian
$280.00
+5,9%
Objectif moyen
$276.41
+4,5%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.01%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 30 juin 2026 | $3.65 | $3.68 | -0.03% |
| 31 mars 2026 | $2.65 | $2.65 | 0.00% |
| 31 décembre 2025 | $2.71 | $2.71 | 0.00% |
| 30 septembre 2025 | $1.86 | $1.81 | 0.05% |
| 30 juin 2025 | $2.97 | $2.94 | 0.03% |
| 31 mars 2025 | $2.46 | $2.43 | 0.03% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| ABBV | — | 96.8 | 8.6% | 6.9% | 15367.3% | — |
| AMGN | $176.35B | 23.0 | 10.0% | 21.0% | 95.9% | — |
| GILD | $152.32B | 18.1 | 2.4% | 28.9% | 40.5% | — |
| VRTX | $115.15B | 29.6 | 8.9% | 32.9% | 22.1% | — |
| REGN | $106.21B | 18.6 | 0.99% | 31.4% | 14.7% | — |
| NTRA | $32.00B | -150.7 | 35.9% | -9.0% | -14.1% | — |
| RVMD | — | — | — | — | — | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $61.16B | $56.33B | $54.32B | $58.05B | $56.20B | $45.80B | $33.27B | $32.75B | $28.22B | $25.64B | $22.86B | $19.96B | |
| Cost of Revenue | $18.20B | $16.90B | $20.41B | $17.41B | $17.45B | $15.39B | $7.44B | $7.72B | $7.04B | $5.83B | $4.50B | $4.43B | |
| SG&A Expense | $14.01B | $14.75B | $12.87B | $15.26B | $12.35B | $11.30B | $6.94B | $7.40B | $6.29B | $5.88B | $6.39B | $7.72B | |
| Operating Expenses | $46.09B | $47.20B | $41.56B | $39.94B | $38.27B | $34.44B | $20.28B | $26.37B | $18.67B | $16.30B | $15.32B | $16.55B | |
| Operating Income | $15.07B | $9.14B | $12.76B | $18.12B | $17.92B | $11.36B | $12.98B | $6.38B | $9.54B | $9.34B | $7.54B | $3.41B | |
| Interest Expense | $2.89B | $2.81B | $2.22B | $2.23B | $2.42B | $2.45B | $1.78B | $1.35B | $1.15B | $1.05B | $719M | $429M | |
| Other Non-op | $-5.79B | $-3.24B | $-4.68B | $-2.45B | $-2.50B | $-5.61B | $-3.01B | $-18M | $-466M | $-188M | $-13M | $27M | |
| Pretax Income | $6.60B | $3.72B | $6.25B | $13.48B | $12.99B | $3.40B | $8.43B | $5.20B | $7.73B | $7.88B | $6.64B | $2.37B | |
| Income Tax | $2.36B | $-570M | $1.38B | $1.63B | $1.44B | $-1.22B | $544M | $-490M | $2.42B | $1.93B | $1.50B | $595M | |
| Net Income | $4.23B | $4.28B | $4.86B | $11.84B | $11.54B | $4.62B | $7.88B | $5.69B | $5.31B | $5.95B | $5.14B | $1.77B | |
| EPS (Basic) | $2.37 | $2.40 | $2.73 | $6.65 | $6.48 | $2.73 | $5.30 | $3.67 | $3.31 | $3.65 | $3.15 | $1.11 | |
| EPS (Diluted) | $2.36 | $2.39 | $2.72 | $6.63 | $6.45 | $2.72 | $5.28 | $3.66 | $3.30 | $3.63 | $3.13 | $1.10 | |
| Shares (Basic) | 1,769,000,000 | 1,769,000,000 | 1,768,000,000 | 1,771,000,000 | 1,770,000,000 | 1,667,000,000 | 1,481,000,000 | 1,541,000,000 | 1,596,000,000 | 1,622,000,000 | 1,625,000,000 | 1,595,000,000 | |
| Shares (Diluted) | 1,773,000,000 | 1,773,000,000 | 1,773,000,000 | 1,778,000,000 | 1,777,000,000 | 1,673,000,000 | 1,484,000,000 | 1,546,000,000 | 1,603,000,000 | 1,631,000,000 | 1,637,000,000 | 1,610,000,000 | |
| EBITDA | $15.07B | $9.14B | $12.76B | $18.12B | $17.92B | $11.36B | $12.98B | $6.38B | $9.59B | $9.38B | $7.54B | $3.41B |
Bilan 26
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5.23B | $5.52B | $12.81B | $9.20B | $9.75B | $8.45B | $39.92B | $7.29B | $9.30B | $5.10B | $8.40B | $8.35B | |
| Short-term Investments | $28M | $31M | $2M | $28M | $84M | $30M | $0 | $772M | $486M | $1.32B | $8M | $26M | |
| Receivables | $12.59B | $10.92B | $11.15B | $11.25B | $9.98B | $8.82B | $5.43B | $5.38B | $5.09B | $4.76B | $4.73B | · | |
| Inventory | $4.95B | $4.18B | $4.10B | $3.58B | $3.13B | $3.31B | $1.81B | $1.60B | $1.60B | $1.44B | $1.72B | $1.12B | |
| Prepaid Expense | $6.29B | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $29.06B | $25.58B | $33.00B | $28.46B | $27.93B | $24.17B | $49.52B | $16.95B | $21.22B | $16.19B | $16.31B | $16.08B | |
| PP&E (Net) | $5.63B | $5.13B | $4.99B | $4.93B | $5.11B | $5.25B | $2.96B | $2.88B | $2.80B | $2.60B | $2.56B | $2.48B | |
| PP&E (Gross) | $13.53B | $12.27B | $11.63B | $10.99B | $10.73B | $10.86B | $8.19B | $8.40B | $8.07B | $7.53B | $7.33B | $7.11B | |
| Accum. Depreciation | $7.90B | $7.13B | $6.65B | $6.05B | $5.62B | $5.61B | $5.23B | $5.51B | $5.27B | $4.92B | $4.77B | $4.62B | |
| Goodwill | $35.64B | $34.96B | $32.29B | $32.16B | $32.38B | $33.12B | $15.60B | $15.66B | $15.79B | $15.42B | $13.17B | $5.86B | |
| Intangibles | $52.64B | $60.07B | $55.61B | $67.44B | $75.95B | $82.88B | $18.65B | $21.23B | $27.56B | $28.90B | $19.71B | $1.51B | |
| Other Non-current Assets | $10.72B | $9.14B | $8.51B | $5.57B | $4.88B | $4.85B | $2.29B | $1.21B | $1.33B | $1.21B | $1.15B | $1.48B | |
| Total Assets | $133.96B | $135.16B | $134.71B | $138.81B | $146.53B | $150.56B | $89.11B | $59.35B | $70.79B | $66.10B | $53.05B | $27.51B | |
| Accounts Payable | $34.73B | $2.94B | $3.69B | $2.93B | $2.88B | $2.28B | $1.45B | $1.55B | $1.47B | $1.41B | $1.60B | $1.40B | |
| Short-term Debt | $2.50B | $0 | $0 | $1M | $14M | $34M | $0 | $3.70B | $400M | $377M | $406M | $425M | |
| Current Liabilities | $43.29B | $38.75B | $37.84B | $29.54B | $35.19B | $28.66B | $15.59B | $17.24B | $16.64B | $9.78B | $10.89B | $11.39B | |
| Capital Leases | $689M | $697M | $735M | $754M | $713M | $832M | · | · | · | · | · | · | |
| Deferred Tax | $2.39B | $2.58B | $1.95B | $2.19B | $3.01B | $3.65B | $1.13B | $1.07B | $2.49B | $6.89B | $5.28B | $159M | |
| Other Non-current Liabilities | $32.57B | $30.13B | $32.33B | $30.66B | $28.70B | $27.61B | $17.60B | $1.31B | $1.24B | $1.16B | $844M | $990M | |
| Long-term Debt | $64.50B | $66.84B | $59.24B | $63.13B | $75.96B | $84.95B | $67.23B | · | · | · | · | · | |
| Total Debt | $2.50B | · | $0 | $1M | $14M | $34M | $0 | $3.70B | $400M | $377M | $406M | $425M | |
| Retained Earnings | $-15.49B | $-7.90B | $-1.00B | $4.78B | $3.13B | $1.05B | $4.72B | $3.37B | $5.46B | $4.38B | $2.25B | $535M | |
| Treasury Stock | $9.15B | $8.20B | $6.53B | $4.59B | $3.14B | $2.26B | $24.50B | $24.11B | $11.92B | $10.85B | $8.84B | $972M | |
| AOCI | $-1.14B | $-1.93B | $-2.31B | $-2.20B | $-2.90B | $-3.12B | $-3.60B | $-2.48B | $-2.73B | $-2.59B | $-2.56B | $-2.03B | |
| Stockholders' Equity | $-3.27B | $3.33B | $10.36B | $17.25B | $15.41B | $13.08B | $-8.17B | $-8.45B | $5.10B | $4.64B | $3.94B | $1.74B | |
| Liabilities + Equity | $133.96B | $135.16B | $134.71B | $138.81B | $146.53B | $150.56B | $89.11B | $59.35B | $70.79B | $66.10B | $53.05B | $27.51B |
Flux de trésorerie 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $955M | $911M | $747M | $671M | $692M | $753M | $430M | $421M | $365M | $353M | $282M | $241M | |
| Deferred Tax | $-492M | $-1.45B | $-2.89B | $-1.93B | $-898M | $-2.33B | $122M | $-1.52B | $-4.16B | $-796M | $152M | $-380M | |
| Amort. of Intangibles | $7.38B | $7.62B | $7.95B | $7.69B | $7.72B | $5.80B | $1.55B | $1.29B | $1.08B | $764M | $419M | $403M | |
| Restructuring | · | · | · | · | · | · | $219M | $59M | $86M | $52M | $126M | $16M | |
| Operating Cash Flow | $19.03B | $18.81B | $22.84B | $24.94B | $22.78B | $17.59B | $13.32B | $13.43B | $9.96B | $7.04B | $7.54B | $3.55B | |
| CapEx | $1.21B | $974M | $777M | $695M | $787M | $798M | $552M | $638M | $529M | $479M | $532M | $612M | |
| Investing Cash Flow | $-6.64B | $-20.82B | $-2.01B | $-623M | $-2.34B | $-37.56B | $596M | $-1.01B | $-274M | · | · | · | |
| Debt Issued | $3.99B | $16.96B | · | $2.00B | $1.00B | $3.00B | $31.48B | $5.96B | $0 | $11.63B | $20.66B | · | |
| Net Debt Issued | $3.99B | $16.96B | · | $2.00B | $1.00B | $3.00B | $31.48B | $5.96B | $0 | $11.63B | $20.66B | · | |
| Stock Repurchased | $980M | $1.71B | $1.97B | $1.49B | $934M | $978M | $629M | $12.01B | $1.41B | $6.03B | $7.59B | $665M | |
| Net Stock Activity | $-980M | $-1.71B | $-1.97B | $-1.49B | $-934M | $-978M | $-629M | $-12.01B | $-1.41B | $-6.03B | $-7.57B | $-652M | |
| Dividends Paid | $11.66B | $11.03B | $10.54B | $10.04B | $9.26B | $7.72B | $6.37B | $5.58B | $4.11B | $3.72B | $3.29B | $2.66B | |
| Financing Cash Flow | $-12.72B | $-5.21B | $-17.22B | $-24.80B | $-19.04B | $-11.50B | $18.71B | $-14.40B | $-5.51B | $-3.93B | · | · | |
| Net Change in Cash | $-295M | $-7.29B | $3.61B | $-545M | $1.30B | $-31.48B | $32.63B | $-2.01B | $4.20B | $-3.30B | $51M | $-1.25B | |
| Taxes Paid | $3.63B | $4.10B | $4.70B | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $17.82B | $17.83B | $22.06B | $24.25B | $21.99B | $16.79B | $12.77B | $12.79B | $9.43B | $6.56B | $7.00B | $2.94B | |
| Levered FCF | $15.96B | $14.59B | $20.33B | $22.29B | $19.84B | $13.45B | $11.10B | $11.31B | $8.64B | $5.77B | $6.45B | $2.62B |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 24.6% | 16.2% | 23.5% | 31.2% | 31.9% | 24.8% | 39.0% | 19.5% | 34.0% | 36.6% | 33.0% | 17.1% | |
| Net Margin | 6.9% | 7.6% | 8.9% | 20.4% | 20.5% | 10.1% | 23.7% | 17.4% | 18.8% | 23.2% | · | · | |
| Pretax Margin | 10.8% | 6.6% | 11.5% | 23.2% | 23.1% | 7.4% | 25.3% | 15.9% | 27.4% | 30.8% | 29.1% | 11.9% | |
| EBITDA Margin | 24.6% | 16.2% | 23.5% | 31.2% | 31.9% | 24.8% | 39.0% | 19.5% | 34.0% | 36.6% | 33.0% | 17.1% | |
| ROA | 3.1% | 3.2% | 3.6% | 8.3% | 7.8% | 3.9% | 10.6% | 8.7% | 7.8% | 10.0% | · | · | |
| ROE | 15367.3% | 62.5% | 35.2% | 72.5% | 81.0% | 188.2% | -94.2% | -100.1% | 109.1% | 138.8% | · | · | |
| ROIC | -1254.6% | 317.0% | 96.0% | 92.3% | 103.3% | 117.9% | -148.6% | -147.1% | 119.9% | 141.3% | 134.1% | 117.9% |
Liquidité et Solvabilité 4
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.7 | 0.9 | 1.0 | 0.8 | 0.8 | 3.2 | 1.0 | 1.3 | 1.7 | 1.5 | 1.4 | |
| Quick Ratio | 0.4 | 0.4 | 0.6 | 0.7 | 0.6 | 0.6 | 2.9 | 0.8 | 0.6 | 0.7 | 0.8 | 0.7 | |
| Debt / Equity | -0.8 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | 0.1 | 0.1 | 0.1 | 0.2 | |
| Interest Coverage | 5.2 | 3.3 | 5.7 | 8.1 | 7.4 | 4.6 | 7.3 | 4.7 | 8.3 | 9.0 | 10.5 | 8.0 |
Efficacité 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.5 | 0.4 | 0.4 | 0.6 | 0.7 | |
| Inventory Turnover | 4.0 | 4.1 | 5.3 | 5.2 | 5.4 | 6.0 | 4.4 | 4.8 | 4.6 | 3.7 | 3.2 | 3.9 | |
| Receivables Turnover | 5.2 | 5.1 | 4.8 | 5.5 | 6.0 | 6.4 | 6.2 | 6.3 | · | · | · | · |
Taux de croissance 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 8.6% | 3.7% | -6.4% | 3.3% | 22.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.8% | 0.08% | 5.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.9% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.3% | -12.1% | -59.0% | 2.8% | 137.1% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -29.1% | -28.2% | 0.00% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -2.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -1.2% | -12.0% | -58.9% | 2.5% | 150.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -29.1% | -28.2% | 1.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -1.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 8.6% | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 6
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $61.16B | $56.33B | $54.32B | $58.05B | $56.20B | $45.80B | $33.27B | $32.75B | $28.22B | $25.64B | $22.86B | $19.96B | |
| Net Income TTM | $4.23B | $4.28B | $4.86B | $11.84B | $11.54B | $4.62B | $7.88B | $5.69B | $5.31B | $5.95B | $5.14B | $1.77B | |
| P/E | 96.8 | 74.4 | 57.0 | 24.4 | 21.0 | 39.4 | 16.8 | 25.2 | 29.3 | 17.3 | 18.9 | 59.5 | |
| Earnings Yield | 1.0% | 1.3% | 1.8% | 4.1% | 4.8% | 2.5% | 6.0% | 4.0% | 3.4% | 5.8% | 5.3% | 1.7% | |
| Payout Ratio | 275.8% | 257.7% | 216.7% | 84.9% | 80.2% | 167.2% | 80.8% | 98.1% | 77.4% | 62.4% | · | · | |
| Annual Payout | $11.66B | $11.03B | $10.54B | $10.04B | $9.26B | $7.72B | $6.37B | $5.58B | $4.11B | $3.72B | $3.29B | $2.66B |
Compte de résultat 17
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.99B | $15.00B | $16.62B | $15.78B | $15.42B | $13.34B | $15.10B | $14.46B | $14.46B | $12.31B | $14.30B | $13.93B | $13.87B | $12.22B | $15.12B | $14.81B | |
| Cost of Revenue | $4.29B | $4.22B | $4.55B | $5.30B | $4.35B | $4.00B | $4.40B | $4.21B | $4.20B | $4.09B | $5.70B | $6.49B | $4.24B | $3.99B | $4.17B | $5.02B | |
| Gross Profit | · | · | $12.07B | · | · | · | $10.71B | · | · | · | $8.60B | · | · | · | $10.95B | · | |
| SG&A Expense | $3.63B | $3.58B | $3.90B | $3.57B | $3.25B | $3.29B | $3.85B | $4.21B | $3.38B | $3.31B | $3.19B | $3.37B | $3.27B | $3.04B | $3.42B | $3.30B | |
| Operating Expenses | $10.56B | $11.01B | $12.07B | $13.87B | $10.53B | $9.61B | $16.59B | $10.63B | $10.46B | $9.51B | $11.11B | $11.65B | $9.35B | $9.46B | $9.62B | $10.21B | |
| Operating Income | $6.43B | $3.99B | $4.54B | $1.90B | $4.89B | $3.73B | $-1.49B | $3.83B | $4.00B | $2.80B | $3.19B | $2.28B | $4.51B | $2.77B | $5.50B | $4.60B | |
| Interest Expense | $746M | $717M | $714M | $739M | $740M | $700M | $702M | $720M | $726M | $660M | $564M | $555M | $552M | $553M | $566M | $560M | |
| Interest Income | $67M | $72M | · | $72M | $62M | $73M | · | $129M | $220M | $207M | · | $157M | $98M | $99M | · | $63M | |
| Other Non-op | $-1.48B | $-2.31B | $-1.21B | $-503M | $-2.66B | $-1.45B | $-150M | $-1.16B | $-1.34B | $-586M | $-1.56B | $95M | $-1.41B | $-1.80B | $-2.02B | $330M | |
| Pretax Income | $4.28B | $1.04B | $2.67B | $714M | $1.55B | $1.66B | $-2.27B | $2.08B | $2.15B | $1.75B | $1.21B | $1.95B | $2.61B | $475M | $2.96B | $4.40B | |
| Income Tax | $662M | $342M | $853M | $526M | $613M | $372M | $-2.25B | $520M | $773M | $383M | $388M | $172M | $583M | $234M | $493M | $448M | |
| Net Income | $3.61B | $695M | $1.82B | $186M | $938M | $1.29B | $-22M | $1.56B | $1.37B | $1.37B | $822M | $1.78B | $2.02B | $239M | $2.47B | $3.95B | |
| EPS (Basic) | $2.04 | $0.39 | $1.02 | $0.10 | $0.52 | $0.72 | $-0.02 | $0.88 | $0.77 | $0.77 | $0.46 | $1.00 | $1.14 | $0.13 | $1.39 | $2.22 | |
| EPS (Diluted) | $2.03 | $0.39 | $1.02 | $0.10 | $0.52 | $0.72 | $-0.03 | $0.88 | $0.77 | $0.77 | $0.45 | $1.00 | $1.14 | $0.13 | $1.40 | $2.21 | |
| Shares (Basic) | 1,769,000,000 | 1,770,000,000 | -3,536,000,000 | 1,769,000,000 | 1,768,000,000 | 1,768,000,000 | -3,537,000,000 | 1,769,000,000 | 1,768,000,000 | 1,769,000,000 | -3,536,000,000 | 1,767,000,000 | 1,767,000,000 | 1,770,000,000 | -3,541,000,000 | 1,771,000,000 | |
| Shares (Diluted) | 1,771,000,000 | 1,774,000,000 | -3,542,000,000 | 1,772,000,000 | 1,771,000,000 | 1,772,000,000 | -3,543,000,000 | 1,772,000,000 | 1,771,000,000 | 1,773,000,000 | -3,545,000,000 | 1,771,000,000 | 1,771,000,000 | 1,776,000,000 | -3,552,000,000 | 1,776,000,000 | |
| EBITDA | $6.43B | $3.99B | · | $1.90B | $4.89B | $3.73B | · | $3.83B | $4.00B | $2.80B | · | $2.28B | $4.51B | $2.77B | · | $4.60B |
Bilan 26
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $6.57B | $9.39B | $5.23B | $5.63B | $6.47B | $5.17B | $5.52B | $7.26B | $13.13B | $18.07B | · | $13.29B | $8.76B | $6.71B | · | $11.83B | |
| Short-term Investments | · | · | $28M | $42M | $0 | $1M | $31M | $28M | $27M | $2M | · | $3M | $7M | $11M | · | $47M | |
| Receivables | $13.82B | $12.48B | $12.59B | $12.77B | $12.64B | $12.48B | $10.92B | $11.47B | $11.72B | $11.95B | · | $11.41B | $11.49B | $11.47B | · | $10.74B | |
| Inventory | $5.13B | $5.05B | $4.95B | $4.94B | $4.96B | $4.53B | $4.18B | $4.45B | $4.22B | $4.25B | · | $3.98B | $4.05B | $3.83B | · | $3.17B | |
| Prepaid Expense | $8.15B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $33.67B | $33.53B | $29.06B | $28.54B | $29.26B | $27.68B | $25.58B | $27.79B | $33.82B | $38.87B | · | $33.22B | $28.85B | $26.49B | · | $30.36B | |
| PP&E (Net) | $5.80B | $5.69B | $5.63B | $5.48B | $5.28B | $5.24B | $5.13B | $5.14B | $5.02B | $4.98B | · | $4.93B | $4.94B | $4.93B | · | $4.89B | |
| PP&E (Gross) | $13.96B | $13.73B | $13.53B | $13.23B | $12.93B | $12.57B | $12.27B | $12.28B | $11.90B | $11.72B | · | $11.37B | $11.32B | $11.14B | · | $10.68B | |
| Accum. Depreciation | $8.16B | $8.04B | $7.90B | $7.75B | $7.65B | $7.33B | $7.13B | $7.14B | $6.88B | $6.75B | · | $6.44B | $6.38B | $6.21B | · | $5.79B | |
| Goodwill | $35.52B | $35.57B | $35.64B | $35.63B | $35.64B | $35.28B | $34.96B | $35.30B | $33.39B | $33.43B | $32.29B | $32.09B | $32.22B | $32.22B | $32.16B | $31.73B | |
| Intangibles | $49.14B | $50.87B | $52.64B | $54.31B | $57.03B | $58.49B | $60.07B | $66.65B | $60.24B | $62.23B | · | $58.60B | $62.86B | $64.85B | · | $68.72B | |
| Other Non-current Assets | $10.73B | $10.54B | $10.72B | $9.64B | $9.66B | $9.19B | $9.14B | $8.29B | $9.20B | $9.07B | · | $7.09B | $6.20B | $5.80B | · | $5.38B | |
| Total Assets | $135.12B | $136.46B | $133.96B | $133.90B | $137.18B | $136.16B | $135.16B | $143.42B | $141.94B | $148.87B | · | $136.22B | $135.37B | $134.54B | · | $141.32B | |
| Accounts Payable | $33.30B | $33.77B | $3.59B | $33.62B | $32.24B | $31.04B | $2.94B | $30.49B | $29.33B | $31.33B | · | $29.66B | $27.04B | $24.79B | · | $23.50B | |
| Short-term Debt | $0 | $0 | $2.50B | $3.79B | $5.56B | $1.59B | $0 | · | · | $3M | · | $2M | $0 | $1M | · | $10M | |
| Current Liabilities | $41.64B | $42.10B | $43.29B | $39.39B | $39.77B | $36.40B | $38.75B | $43.06B | $41.91B | $41.52B | · | $34.77B | $32.24B | $27.59B | · | $32.71B | |
| Capital Leases | · | · | $689M | · | · | · | $697M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $2.28B | $2.33B | $2.39B | $2.48B | $2.55B | $2.58B | $2.58B | $2.75B | $2.73B | $2.72B | · | $2.04B | $2.12B | $2.11B | · | $1.97B | |
| Other Non-current Liabilities | $34.60B | $34.11B | $32.57B | $31.66B | $32.04B | $31.19B | $30.13B | $33.03B | $32.43B | $32.78B | · | $31.64B | $32.29B | $32.25B | · | $30.21B | |
| Long-term Debt | · | · | $64.50B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $0 | $0 | · | $3.79B | $5.56B | $1.59B | · | · | · | $3M | · | $2M | $0 | $1M | · | $10M | |
| Retained Earnings | $-17.33B | $-17.87B | $-15.49B | $-14.23B | $-11.50B | $-9.53B | $-7.90B | $-4.96B | $-3.77B | $-2.38B | · | $933M | $1.79B | $2.39B | · | $4.95B | |
| Treasury Stock | $10.62B | $10.61B | $9.15B | $9.14B | $9.15B | $9.14B | $8.20B | $7.85B | $7.84B | $7.83B | · | $6.53B | $6.53B | $6.52B | · | $4.59B | |
| AOCI | $-1.16B | $-1.15B | $-1.14B | $-1.57B | $-1.54B | $-1.74B | $-1.93B | $-2.33B | $-2.51B | $-2.45B | · | $-2.35B | $-2.25B | $-2.23B | · | $-3.44B | |
| Stockholders' Equity | $-5.93B | $-6.66B | $-3.27B | $-2.64B | $-183M | $1.42B | $3.33B | $6.03B | $6.78B | $8.01B | · | $12.09B | $12.87B | $13.27B | · | $15.99B | |
| Liabilities + Equity | $135.12B | $136.46B | $133.96B | $133.90B | $137.18B | $136.16B | $135.16B | $143.42B | $141.94B | $148.87B | · | $136.22B | $135.37B | $134.54B | · | $141.32B |
Flux de trésorerie 15
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $166M | $444M | $157M | $209M | $179M | $410M | $164M | $181M | $218M | $348M | $125M | $130M | $179M | $313M | $132M | $126M | |
| Deferred Tax | $-195M | $137M | $-385M | $193M | $-272M | $-28M | $-767M | $-277M | $-16M | $-389M | $-1.39B | $-863M | $-368M | $-267M | $-516M | $-621M | |
| Amort. of Intangibles | $1.70B | $1.75B | $1.72B | $1.90B | $1.90B | $1.86B | $1.93B | $1.90B | $1.90B | $1.89B | $1.90B | $2.00B | $2.10B | $1.95B | $2.03B | $2.00B | |
| Operating Cash Flow | $3.44B | $3.83B | $5.22B | $7.02B | $5.15B | $1.64B | $7.05B | $5.45B | $2.27B | $4.04B | $4.75B | $7.57B | $6.32B | $4.19B | $7.43B | $7.60B | |
| CapEx | $322M | $265M | $329M | $381M | $269M | $235M | $291M | $249M | $241M | $193M | $205M | $219M | $178M | $175M | $213M | $177M | |
| Investing Cash Flow | $-1.20B | $-574M | $-1.46B | $-3.26B | $-1.18B | $-735M | $-1.87B | $-8.26B | $-1.10B | $-9.59B | $-800M | $-369M | $-341M | $-499M | $-448M | $1.29B | |
| Debt Issued | $0 | $7.99B | $0 | $0 | $0 | $3.99B | $2.00B | $0 | $0 | $14.96B | · | $0 | $0 | $0 | $0 | $0 | |
| Net Debt Issued | · | $7.99B | · | · | · | $3.99B | · | · | · | $14.96B | · | · | · | $0 | · | · | |
| Stock Repurchased | $9M | $1.49B | $3M | $4M | $12M | $961M | $358M | $17M | $9M | $1.32B | $3M | $4M | $10M | $1.96B | $4M | $4M | |
| Net Stock Activity | · | $-1.49B | · | · | · | $-961M | · | · | · | $-1.32B | · | · | · | $-1.96B | · | · | |
| Dividends Paid | $3.07B | $3.09B | $2.91B | $2.91B | $2.91B | $2.92B | $2.75B | $2.75B | $2.75B | $2.77B | $2.63B | $2.63B | $2.62B | $2.66B | $2.51B | $2.50B | |
| Financing Cash Flow | $-5.05B | $919M | $-4.17B | $-4.59B | $-2.71B | $-1.26B | $-6.86B | $-3.07B | $-6.10B | $10.82B | $-4.45B | $-2.66B | $-3.92B | $-6.19B | $-9.63B | $-5.52B | |
| Net Change in Cash | $-2.82B | $4.16B | $-400M | $-838M | $1.29B | $-349M | $-1.73B | $-5.87B | $-4.94B | $5.25B | $-473M | $4.53B | $2.05B | $-2.49B | $-2.63B | $3.31B | |
| Free Cash Flow | · | $3.56B | · | · | · | $1.40B | · | · | · | $3.85B | · | · | · | $4.02B | · | · | |
| Levered FCF | · | $3.08B | · | · | · | $857M | · | · | · | $3.33B | · | · | · | $3.74B | · | · |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 37.9% | 26.6% | · | 12.1% | 31.7% | 28.0% | · | 26.5% | 27.6% | 22.7% | · | 16.4% | 32.6% | 22.6% | · | 31.1% | |
| Net Margin | 21.3% | 4.6% | · | 1.2% | 6.1% | 9.6% | · | 10.8% | 9.5% | 11.1% | · | 12.8% | 14.6% | 2.0% | · | 26.7% | |
| Pretax Margin | 25.2% | 6.9% | · | 4.5% | 10.1% | 12.4% | · | 14.4% | 14.8% | 14.3% | · | 14.0% | 18.8% | 3.9% | · | 29.7% | |
| EBITDA Margin | 37.9% | 26.6% | · | 12.1% | 31.7% | 28.0% | · | 26.5% | 27.6% | 22.7% | · | 16.4% | 32.6% | 22.6% | · | 31.1% | |
| ROA | 2.6% | 0.51% | · | 0.13% | 0.67% | 0.90% | · | 1.1% | 0.99% | 0.97% | · | 1.3% | 1.5% | 0.17% | · | 2.7% | |
| ROE | -118.1% | -26.6% | · | 11.0% | 28.4% | 27.3% | · | 17.2% | 14.0% | 12.9% | · | 12.7% | 14.7% | 1.6% | · | 26.7% | |
| ROIC | -91.6% | -40.2% | · | 43.7% | 55.2% | 96.2% | · | 47.7% | 37.7% | 27.3% | · | 17.2% | 27.2% | 10.6% | · | 25.8% |
Liquidité et Solvabilité 4
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | 0.8 | 0.9 | · | 1.0 | 0.9 | 1.0 | · | 0.9 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.4 | 0.6 | 0.7 | · | 0.7 | 0.6 | 0.7 | · | 0.7 | |
| Debt / Equity | 0.0 | 0.0 | · | -1.4 | -30.4 | 1.1 | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Interest Coverage | 8.6 | 5.6 | · | 2.6 | 6.6 | 5.3 | · | 5.3 | 5.5 | 4.2 | · | 4.1 | 8.2 | 5.0 | · | 8.2 |
Efficacité 3
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.9 | 0.9 | · | 1.1 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.8 | 1.1 | 1.1 | · | 1.6 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.3 | 1.3 | 1.1 | · | 1.3 | 1.2 | 1.1 | · | 1.3 | 1.2 | 1.1 | · | 1.5 |
Valorisation (TTM) 5
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $64.39B | $62.82B | · | $59.64B | $58.33B | $57.37B | · | $55.53B | $55.00B | $54.40B | · | $55.14B | $56.02B | $56.74B | · | $57.82B | |
| Net Income TTM | $6.31B | $3.63B | · | $2.39B | $3.76B | $4.20B | · | $5.12B | $5.34B | $5.99B | · | $6.51B | $8.69B | $7.58B | · | $13.41B | |
| P/E | 71.1 | 107.1 | · | 175.4 | 88.4 | 89.2 | · | 68.6 | 57.2 | 54.0 | · | 40.8 | 27.7 | 37.7 | · | 17.9 | |
| Earnings Yield | 1.4% | 0.93% | · | 0.57% | 1.1% | 1.1% | · | 1.5% | 1.8% | 1.8% | · | 2.5% | 3.6% | 2.6% | · | 5.6% | |
| Payout Ratio | · | 444.0% | · | · | · | 227.5% | · | · | · | 202.5% | · | · | · | 1113.4% | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $61.16B | $56.33B | $54.32B | $58.05B | $56.20B |
| Marge d'exploitation % | 24.6% | 16.2% | 23.5% | 31.2% | 31.9% |
| Résultat net | $4.23B | $4.28B | $4.86B | $11.84B | $11.54B |
| BPA dilué | $2.36 | $2.39 | $2.72 | $6.63 | $6.45 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | -0.8 | — | 0.0 | 0.0 | 0.0 |
| Ratio de liquidité | 0.7 | 0.7 | 0.9 | 1.0 | 0.8 |
| Ratio de liquidité réduite | 0.4 | 0.4 | 0.6 | 0.7 | 0.6 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $17.82B | $17.83B | $22.06B | $24.25B | $21.99B |
Dernières actualités Actualités récentes mentionnant cette entreprise
- Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?
- How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?
- AbbVie est déjà un roi des dividendes. Voici pourquoi l'accord Apogee à 10,9 milliards de dollars pourrait en faire une dynastie
- AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?
- AbbVie (ABBV) to Acquire Apogee Therapeutics
- Is AbbVie a Buy After Its Purchase of Apogee?
- Canaccord Says AbbVie’s (ABBV) Apogee Deal Strengthens Long-Term Growth Outlook
- AbbVie Just Sparked a 46% Rally in Apogee. Here’s Why This $10.9 Billion Deal Could Be a Win for AbbVie Investors.
- Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger
- The $11 Billion Reason Abbvie Stock Is Up Today
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 4 558 déclarants · $203.6B total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 255 (+20 vs T. préc.) | 102 (-73 vs T. préc.) | 1 854 (+162 vs T. préc.) | 1 495 (-188 vs T. préc.) | +245.1M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $29 038 274 101 | 115 396 098 | 14,26% | Actions |
| STATE STREET CORP | $20 784 645 667 | 82 596 748 | 10,21% | Actions |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $12 199 002 913 | 48 477 996 | 5,99% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $10 348 337 446 | 41 208 853 | 5,08% | Actions |
| Capital Research Global Investors | $7 574 798 407 | 30 101 551 | 3,72% | Actions |
| NORGES BANK | $6 430 543 942 | 25 554 538 | 3,16% | Actions |
| Capital World Investors | $4 826 436 854 | 19 178 966 | 2,37% | Actions |
| Capital International Investors | $3 936 357 038 | 15 638 631 | 1,93% | Actions |
| FMR LLC | $3 669 614 638 | 14 582 795 | 1,80% | Actions |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3 235 535 863 | 12 854 734 | 1,59% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $2 501 249 007 | 9 939 791 | 1,23% | Actions |
| Fisher Asset Management, LLC | $2 390 069 445 | 9 497 970 | 1,17% | Actions |
| VANGUARD GROUP INC | $2 321 825 812 | 10 161 608 | 1,14% | Actions |
| AMERIPRISE FINANCIAL INC | $2 300 268 904 | 9 140 996 | 1,13% | Actions |
| UBS Group AG | $1 821 262 870 | 7 237 573 | 0,89% | Actions |
| RAYMOND JAMES FINANCIAL INC | $1 804 931 470 | 7 172 673 | 0,89% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $1 626 458 497 | 6 463 432 | 0,80% | Actions |
| BANK OF AMERICA CORP /DE/ | $1 288 677 353 | 5 121 115 | 0,63% | Actions |
| BlackRock, Inc. | $1 281 498 844 | 5 092 588 | 0,63% | Actions |
| Swiss National Bank | $1 255 358 984 | 4 988 710 | 0,62% | Actions |
| GOLDMAN SACHS GROUP INC | $1 238 268 174 | 4 920 792 | 0,61% | Actions |
| ENVESTNET ASSET MANAGEMENT INC | $1 229 678 938 | 4 886 670 | 0,60% | Actions |
| WELLINGTON MANAGEMENT GROUP LLP | $1 194 403 724 | 4 746 478 | 0,59% | Actions |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1 092 298 708 | 4 340 720 | 0,54% | Actions |
| LPL Financial LLC | $1 030 798 580 | 4 096 323 | 0,51% | Actions |
| National Pension Service | $1 008 968 950 | 4 009 573 | 0,50% | Actions |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 005 413 025 | 3 995 442 | 0,49% | Actions |
| Sumitomo Mitsui Trust Group, Inc. | $992 857 195 | 3 945 546 | 0,49% | Actions |
| Vanguard Global Advisers, LLC | $963 609 833 | 3 829 319 | 0,47% | Actions |
| Robeco Institutional Asset Management B.V. | $897 126 545 | 3 565 119 | 0,44% | Actions |
| Legal & General Group Plc | $895 484 594 | 3 558 594 | 0,44% | Actions |
| ALLIANCEBERNSTEIN L.P. | $890 041 939 | 4 092 335 | 0,44% | Actions |
| California Public Employees Retirement System | $862 671 241 | 3 428 196 | 0,42% | Actions |
| CANADA PENSION PLAN INVESTMENT BOARD | $817 473 174 | 3 248 582 | 0,40% | Actions |
| CITADEL ADVISORS LLC | $797 644 194 | 3 169 783 | 0,39% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $768 828 394 | 3 055 271 | 0,38% | Actions |
| BARCLAYS PLC | $739 133 865 | 2 937 267 | 0,36% | Actions |
| NORDEA INVESTMENT MANAGEMENT AB | $721 397 794 | 2 869 636 | 0,35% | Actions |
| RHUMBLINE ADVISERS | $687 895 224 | 2 733 648 | 0,34% | Actions |
| PRINCIPAL FINANCIAL GROUP INC | $667 358 842 | 2 652 038 | 0,33% | Actions |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $655 267 540 | 2 603 988 | 0,32% | Actions |
| TD Asset Management Inc | $648 811 716 | 2 578 333 | 0,32% | Actions |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $631 733 198 | 2 904 654 | 0,31% | Actions |
| PNC Financial Services Group, Inc. | $625 922 542 | 2 487 373 | 0,31% | Actions |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | $584 076 068 | 2 321 078 | 0,29% | Actions |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $582 914 088 | 2 680 188 | 0,29% | Actions |
| FIFTH THIRD BANCORP | $541 376 862 | 2 151 394 | 0,27% | Actions |
| Assenagon Asset Management S.A. | $527 911 026 | 2 097 882 | 0,26% | Actions |
| JANE STREET GROUP, LLC | $520 089 552 | 2 066 800 | 0,26% | Option d'achat |
| CITADEL ADVISORS LLC | $500 839 092 | 1 990 300 | 0,25% | Option d'achat |
| JANE STREET GROUP, LLC | $499 555 728 | 1 985 200 | 0,25% | Option de vente |
| HighTower Advisors, LLC | $495 062 218 | 1 967 343 | 0,24% | Actions |
| NEW YORK STATE COMMON RETIREMENT FUND | $485 540 135 | 1 929 503 | 0,24% | Actions |
| GQG Partners LLC | $483 559 978 | 1 921 614 | 0,24% | Actions |
| PRUDENTIAL FINANCIAL INC | $478 733 776 | 1 902 455 | 0,24% | Actions |
| Fayez Sarofim & Co | $464 570 323 | 1 846 170 | 0,23% | Actions |
| CAPTRUST FINANCIAL ADVISORS | $457 328 195 | 1 817 391 | 0,22% | Actions |
| US BANCORP \DE\ | $431 161 990 | 1 713 408 | 0,21% | Actions |
| MACKENZIE FINANCIAL CORP | $429 747 269 | 1 707 786 | 0,21% | Actions |
| AVIVA PLC | $418 894 036 | 1 664 656 | 0,21% | Actions |
| AMERICAN CENTURY COMPANIES INC | $417 685 426 | 1 659 851 | 0,21% | Actions |
| Caisse de depot et placement du Quebec | $413 100 025 | 1 641 631 | 0,20% | Actions |
| Baird Financial Group, Inc. | $408 320 931 | 1 622 639 | 0,20% | Actions |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $402 263 652 | 1 598 568 | 0,20% | Actions |
| VICTORY CAPITAL MANAGEMENT INC | $398 029 187 | 1 581 740 | 0,20% | Actions |
| Eurizon Capital SGR S.p.A. | $382 266 246 | 1 515 159 | 0,19% | Actions |
| MILLENNIUM MANAGEMENT LLC | $381 605 769 | 1 516 475 | 0,19% | Actions |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $379 803 020 | 1 509 311 | 0,19% | Actions |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $358 269 921 | 1 448 017 | 0,18% | Actions |
| APG Asset Management N.V. | $355 105 573 | 1 613 385 | 0,17% | Actions |
| CINCINNATI INSURANCE CO | $353 604 528 | 1 405 200 | 0,17% | Actions |
| CITADEL ADVISORS LLC | $352 698 624 | 1 401 600 | 0,17% | Option de vente |
| Alecta Tjanstepension Omsesidigt | $350 097 440 | 1 393 700 | 0,17% | Actions |
| UBS Group AG | $347 253 386 | 1 379 961 | 0,17% | Option d'achat |
| ROYAL LONDON ASSET MANAGEMENT LTD | $337 822 422 | 1 342 483 | 0,17% | Actions |
| Korea Investment CORP | $324 892 907 | 1 291 102 | 0,16% | Actions |
| BLAIR WILLIAM & CO/IL | $324 076 456 | 1 287 857 | 0,16% | Actions |
| CIBC Bancorp USA Inc. | $319 137 398 | 1 268 149 | 0,16% | Actions |
| NEUBERGER BERMAN GROUP LLC | $312 155 419 | 1 240 484 | 0,15% | Actions |
| KEYBANK NATIONAL ASSOCIATION/OH | $297 253 749 | 1 181 266 | 0,15% | Actions |
| PFA Pension, Forsikringsaktieselskab | $296 007 110 | 1 176 312 | 0,15% | Actions |
| Candriam S.C.A. | $292 814 436 | 1 164 745 | 0,14% | Actions |
| BANK OF MONTREAL /CAN/ | $287 298 646 | 1 141 705 | 0,14% | Actions |
| MENORA MIVTACHIM HOLDINGS LTD. | $286 660 236 | 1 139 168 | 0,14% | Actions |
| Quantinno Capital Management LP | $286 551 564 | 1 138 736 | 0,14% | Actions |
| CITIGROUP INC | $284 177 052 | 1 129 300 | 0,14% | Option de vente |
| D. E. Shaw & Co., Inc. | $279 166 396 | 1 109 388 | 0,14% | Actions |
| Nuveen, LLC | $278 124 451 | 1 105 247 | 0,14% | Actions |
| Public Sector Pension Investment Board | $273 989 658 | 1 088 816 | 0,13% | Actions |
| STOREBRAND ASSET MANAGEMENT AS | $271 386 191 | 1 078 470 | 0,13% | Actions |
| ProShare Advisors LLC | $270 105 595 | 1 073 381 | 0,13% | Actions |
| Aberdeen Group plc | $269 639 809 | 1 071 530 | 0,13% | Actions |
| Guinness Asset Management LTD | $261 219 378 | 1 042 337 | 0,13% | Actions |
| TRUIST FINANCIAL CORP | $259 417 636 | 1 030 908 | 0,13% | Actions |
| Cerity Partners LLC | $251 309 055 | 998 667 | 0,12% | Actions |
| Cetera Investment Advisers | $249 297 571 | 990 692 | 0,12% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $246 700 034 | 973 752 | 0,12% | Actions |
| COMMONWEALTH EQUITY SERVICES, LLC | $245 375 470 | 975 105 | 0,12% | Actions |
| FEDERATED HERMES, INC. | $244 359 552 | 971 068 | 0,12% | Actions |
| SATURNA CAPITAL CORP | $240 562 538 | 958 069 | 0,12% | Actions |
Initiés de la société 33 initiés · 17 dirigeants · 13 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Nicholas Donoghoe | EVP, CHIEF BUS/STRAT OFFICER | 14 août 2026 M | 74 430 | 0 | 1 | $-8 177 500 |
| Richard A Gonzalez | EXECUTIVE CHAIRMAN OF BOARD | 17 juillet 2024 M | 513 099 | 0 | 0 | $0 |
| Michael Severino | Vice Chairman | 23 mai 2022 M | 152 103 | 0 | 0 | $0 |
| Henry O Gosebruch | EVP, Chief Strategy Officer | 16 mai 2022 M | 41 623 | 0 | 0 | $0 |
| Carrie C Strom | SVP & Pres Global Allerg Aesth | 11 mai 2022 F | 40 663 | 0 | 0 | $0 |
| Jeffrey Ryan Stewart | EVP, Chief Commercial Officer | 24 mars 2022 M | 60 941 | 0 | 0 | $0 |
| Brian L Durkin | VP, Controller | 9 mars 2022 M | 19 094 | 0 | 0 | $0 |
| Elaine K. Sorg | SVP, US Commercial Operations | 1 mars 2022 S | 17 876 | 0 | 0 | $0 |
| Robert A. Michael | Vice Chairman | 1 mars 2022 S | 37 877 | 0 | 0 | $0 |
| Timothy J. Richmond | EVP, Chief HR Officer | 1 mars 2022 S | 13 837 | 0 | 0 | $0 |
| Thomas J Hudson | SVP, R&D and CSO | 25 février 2022 F | 46 228 | 0 | 0 | $0 |
| Azita Saleki-Gerhardt | EVP, Operations | 25 février 2022 F | 157 912 | 0 | 0 | $0 |
| Laura J Schumacher | Vice Chairman | 25 février 2022 F | 248 002 | 0 | 0 | $0 |
| Carlos Alban | Vice Chairman | 16 novembre 2020 M | 114 899 | 0 | 0 | $0 |
| William J Chase | EVP, Finance & Administration | 26 juin 2019 P | 169 552 | 0 | 0 | $0 |
| Thomas A. Hurwich | VP, Controller | 28 février 2017 F | 62 329 | 0 | 0 | $0 |
| John M. Leonard | SVP, Chief Scientific Officer | 15 mars 2013 M | 107 320 | 0 | 0 | $0 |
| Susan E Quaggin | Administrateur | 30 juin 2026 A | — | 0 | 0 | $0 |
| Edward J Rapp | Administrateur | 30 juin 2026 A | 45 964 | 0 | 0 | $0 |
| Frederick H Waddell | Administrateur | 8 mai 2026 A | 30 076 | 0 | 0 | $0 |
| Thomas J Falk | Administrateur | 8 mai 2026 A | 2 321 | 0 | 0 | $0 |
| Roxanne S Austin | Administrateur | 8 mai 2026 A | 39 576 | 0 | 0 | $0 |
| Robert J Alpern | Administrateur | 30 juin 2024 A | 31 542 | 0 | 0 | $0 |
| Melody B Meyer | Administrateur | 6 mai 2022 A | 12 523 | 0 | 0 | $0 |
| William H.L. Burnside | Administrateur | 6 mai 2022 A | 22 983 | 0 | 0 | $0 |
| Brett J Hart | Administrateur | 6 mai 2022 A | 15 497 | 0 | 0 | $0 |
| Glenn F Tilton | Administrateur | 6 mai 2022 A | 47 589 | 0 | 0 | $0 |
| Edward M Liddy | Administrateur | 31 mars 2022 A | 26 683 | 0 | 0 | $0 |
| Roy S Roberts | Administrateur | 8 mai 2015 A | 27 486 | 0 | 0 | $0 |
| AbbVie Inc. | Détenteur de 10% | 28 mars 2017 S | 1 190 473 | 0 | 0 | $0 |
| ABBOTT LABORATORIES | Détenteur de 10% | 12 décembre 2012 J | 0 | 0 | 0 | $0 |
| Rebecca B Roberts | — | 8 mai 2026 A | 14 846 | 0 | 0 | $0 |
| Thomas C Freyman | — | 8 mai 2026 A | 127 869 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 1 participation
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| AbbVie Inc. | 6 octobre 2017 | — | Dépôt initial | Fusions et acquisitions / vente | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 284 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IYH · iShares Trust | 7,02% | 1 060 126 SH | 8 août 2026 | Quotidien |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 6,58% | 3 464 NS | 30 avril 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 6,56% | 5 317 086 SH | 8 août 2026 | Quotidien |
| FHLC · FIDELITY COVINGTON TRUST | 6,03% | 814 750 NS | 30 avril 2026 | N-PORT |
| HDV · iShares Trust | 5,99% | 3 630 784 SH | 8 août 2026 | Quotidien |
| RXL · ProShares Trust | 5,57% | 18 435 NS | 31 mai 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 5,39% | 35 243 NS | 30 avril 2026 | N-PORT |
| PJP · Invesco Exchange-Traded Fund Trust | 5,25% | 107 387 SH | 8 août 2026 | Quotidien |
| IXJ · iShares Trust | 4,83% | 824 169 SH | 8 août 2026 | Quotidien |
| MEDI · Harbor ETF Trust | 4,78% | 6 235 NS | 30 avril 2026 | N-PORT |
| LCOW · Pacer Funds Trust | 4,28% | 4 651 NS | 30 avril 2026 | N-PORT |
| FLAG · Global X Funds | 4,27% | 333 NS | 30 avril 2026 | N-PORT |
| FDV · Federated Hermes ETF Trust | 3,86% | 136 965 NS | 30 avril 2026 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 3,59% | 259 875 SH | 8 août 2026 | Quotidien |
| AGNG · Global X Funds | 3,16% | 11 869 NS | 31 mai 2026 | N-PORT |
| ABOT · Abacus FCF ETF Trust | 2,85% | 594 NS | 30 avril 2026 | N-PORT |
| DGRO · iShares Trust | 2,84% | 5 057 158 SH | 8 août 2026 | Quotidien |
| CANC · Tema ETF Trust | 2,81% | 22 700 NS | 31 mai 2026 | N-PORT |
| PAYR · Federated Hermes ETF Trust | 2,69% | 4 656 NS | 30 avril 2026 | N-PORT |
| QDEF · FlexShares Trust | 2,66% | 66 732 NS | 30 avril 2026 | N-PORT |
| QDF · FlexShares Trust | 2,63% | 264 330 NS | 30 avril 2026 | N-PORT |
| SNPV · DBX ETF Trust | 2,62% | 27 726 NS | 29 mai 2026 | N-PORT |
| ABFL · Abacus FCF ETF Trust | 2,48% | 58 404 NS | 30 avril 2026 | N-PORT |
| DIVY · Tidal Trust I | 2,42% | 3 163 NS | 31 mai 2026 | N-PORT |
| HRTS · Tema ETF Trust | 2,40% | 5 714 NS | 31 mai 2026 | N-PORT |
| GEND · Spinnaker ETF Series | 2,35% | 498 NS | 30 avril 2026 | N-PORT |
| XT · iShares Trust | 2,32% | 372 278 SH | 8 août 2026 | Quotidien |
| FLCC · Federated Hermes ETF Trust | 2,20% | 12 240 NS | 31 mai 2026 | N-PORT |
| VUSE · ETF Series Solutions | 2,15% | 67 918 NS | 31 mai 2026 | N-PORT |
| QLV · FlexShares Trust | 2,13% | 17 108 NS | 30 avril 2026 | N-PORT |
| CGCV · Capital Group Conservative Equity E… | 2,13% | 171 487 NS | 31 mai 2026 | N-PORT |
| MGV · VANGUARD WORLD FUND | 2,10% | 1 110 490 SH | 8 août 2026 | Quotidien |
| FDIV · EA Series Trust | 2,10% | 7 229 NS | 30 avril 2026 | N-PORT |
| FLCG · Federated Hermes ETF Trust | 2,04% | 53 408 NS | 31 mai 2026 | N-PORT |
| BSCQ · Invesco Exchange-Traded Self-Indexe… | 1,99% | 70 705 000 | 8 août 2026 | Quotidien |
| VIG · VANGUARD SPECIALIZED FUNDS | 1,94% | 9 981 469 SH | 8 août 2026 | Quotidien |
| PJFV · PGIM ETF Trust | 1,90% | 7 518 NS | 29 mai 2026 | N-PORT |
| SWP · Manager Directed Portfolios | 1,89% | 13 423 NS | 31 mai 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 1,87% | 4 006 NS | 30 avril 2026 | N-PORT |
| SDOG · ALPS ETF Trust | 1,87% | 118 805 NS | 31 mai 2026 | N-PORT |
| ANEW · ProShares Trust | 1,86% | 661 NS | 31 mai 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 1,85% | 7 067 444 SH | 8 août 2026 | Quotidien |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 1,83% | 54 664 000 | 8 août 2026 | Quotidien |
| JDIV · J.P. Morgan Exchange-Traded Fund Tr… | 1,81% | 959 NS | 30 avril 2026 | N-PORT |
| CAPE · DoubleLine ETF Trust | 1,80% | 21 524 NS | 31 mars 2026 | N-PORT |
| CRTC · DBX ETF Trust | 1,79% | 10 704 NS | 31 mai 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 1,73% | 814 NS | 31 mai 2026 | N-PORT |
| DIVB · iShares Trust | 1,72% | 124 706 SH | 8 août 2026 | Quotidien |
| NULV · Nushares ETF Trust | 1,68% | 164 634 NS | 30 avril 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,67% | 52 710 SH | 8 août 2026 | Quotidien |